102 related articles for article (PubMed ID: 27379838)
1. MicroRNA-205-5p is upregulated in myelodysplastic syndromes and induces cell proliferation via PTEN suppression.
Jang SJ; Choi IS; Park G; Moon DS; Choi JS; Nam MH; Yoon SY; Choi CH; Kang SH
Leuk Res; 2016 Aug; 47():172-7. PubMed ID: 27379838
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-194-5p could serve as a diagnostic and prognostic biomarker in myelodysplastic syndromes.
Choi JS; Nam MH; Yoon SY; Kang SH
Leuk Res; 2015 Jul; 39(7):763-8. PubMed ID: 25975751
[TBL] [Abstract][Full Text] [Related]
3. Over-expression of miR-196b-5p is significantly associated with the progression of myelodysplastic syndrome.
Wen J; Huang Y; Li H; Zhang X; Cheng P; Deng D; Peng Z; Luo J; Zhao W; Lai Y; Liu Z
Int J Hematol; 2017 Jun; 105(6):777-783. PubMed ID: 28224273
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-661 upregulation in myelodysplastic syndromes induces apoptosis through p53 activation and associates with decreased overall survival.
Kang SH; Choi JS
Leuk Lymphoma; 2019 Nov; 60(11):2779-2786. PubMed ID: 31056984
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of microRNA-597 in myelodysplastic syndromes induces apoptosis through FOSL2 inhibition.
Kang SH; Kim HB; Choi JS
Eur J Haematol; 2022 Dec; 109(6):680-685. PubMed ID: 36018564
[TBL] [Abstract][Full Text] [Related]
6. Identification of microRNA-regulated pathways using an integration of microRNA-mRNA microarray and bioinformatics analysis in CD34+ cells of myelodysplastic syndromes.
Xu F; Zhu Y; He Q; Wu LY; Zhang Z; Shi WH; Liu L; Chang CK; Li X
Sci Rep; 2016 Aug; 6():32232. PubMed ID: 27571714
[TBL] [Abstract][Full Text] [Related]
7. Aberrant microRNA expression pattern in myelodysplastic bone marrow cells.
Hussein K; Theophile K; Büsche G; Schlegelberger B; Göhring G; Kreipe H; Bock O
Leuk Res; 2010 Sep; 34(9):1169-74. PubMed ID: 20627384
[TBL] [Abstract][Full Text] [Related]
8. Expression analysis of mir-17-5p, mir-20a and let-7a microRNAs and their target proteins in CD34+ bone marrow cells of patients with myelodysplastic syndromes.
Vasilatou D; Papageorgiou SG; Kontsioti F; Kontos CK; Tsiotra P; Mpakou V; Pavlou MA; Economopoulou C; Dimitriadis G; Dervenoulas J; Pappa V
Leuk Res; 2013 Mar; 37(3):251-8. PubMed ID: 23246221
[TBL] [Abstract][Full Text] [Related]
9. A plasma microRNA signature as a biomarker for acquired aplastic anemia.
Hosokawa K; Kajigaya S; Feng X; Desierto MJ; Fernandez Ibanez MD; Rios O; Weinstein B; Scheinberg P; Townsley DM; Young NS
Haematologica; 2017 Jan; 102(1):69-78. PubMed ID: 27658437
[TBL] [Abstract][Full Text] [Related]
10. Myelodysplastic syndromes: Aiming at deciphering their secrets.
Diamantidis MD; Papanastasiou D
Leuk Res; 2016 Dec; 51():1-2. PubMed ID: 27769008
[No Abstract] [Full Text] [Related]
11. MiR-106b-5p Inhibits Tumor Necrosis Factor-α-induced Apoptosis by Targeting Phosphatase and Tensin Homolog Deleted on Chromosome 10 in Vascular Endothelial Cells.
Zhang J; Li SF; Chen H; Song JX
Chin Med J (Engl); 2016 Jun; 129(12):1406-12. PubMed ID: 27270534
[TBL] [Abstract][Full Text] [Related]
12. Significant inverse correlation of microRNA-150/MYB and microRNA-222/p27 in myelodysplastic syndrome.
Hussein K; Theophile K; Büsche G; Schlegelberger B; Göhring G; Kreipe H; Bock O
Leuk Res; 2010 Mar; 34(3):328-34. PubMed ID: 19615744
[TBL] [Abstract][Full Text] [Related]
13. miRNA expression profiles in myelodysplastic syndromes reveal Epstein-Barr virus miR-BART13 dysregulation.
Borze I; Scheinin I; Siitonen S; Elonen E; Juvonen E; Knuutila S
Leuk Lymphoma; 2011 Aug; 52(8):1567-73. PubMed ID: 21649547
[TBL] [Abstract][Full Text] [Related]
14. Non-Specific Blocking of miR-17-5p Guide Strand in Triple Negative Breast Cancer Cells by Amplifying Passenger Strand Activity.
Jin YY; Andrade J; Wickstrom E
PLoS One; 2015; 10(12):e0142574. PubMed ID: 26629823
[TBL] [Abstract][Full Text] [Related]
15. [Expression of miR-550a-5p in Myelodysplastic Syndrome and Its Prediction of Target Genes].
Huang Y; Wen J; Li HY; Zhang XP; Deng DH; Cheng P; Peng ZG; Zhao WH; Luo J; Long Y; Liu ZF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1476-1483. PubMed ID: 27784378
[TBL] [Abstract][Full Text] [Related]
16. MiR-138-5p promotes TNF-α-induced apoptosis in human intervertebral disc degeneration by targeting SIRT1 through PTEN/PI3K/Akt signaling.
Wang B; Wang D; Yan T; Yuan H
Exp Cell Res; 2016 Jul; 345(2):199-205. PubMed ID: 27207584
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
[TBL] [Abstract][Full Text] [Related]
18. Microarray analysis of differentially expressed microRNAs in myelodysplastic syndromes.
Wan C; Wen J; Huang Y; Li H; Wu W; Xie Q; Liang X; Tang Z; Zhao W; Cheng P; Liu Z
Medicine (Baltimore); 2020 Jul; 99(27):e20904. PubMed ID: 32629683
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-590-5p promotes cell survival in endometrioid endometrial cancer by suppressing tumor suppressor PTEN.
Zhu M; Zhou X; Zhang J; Zhang Y
Int J Clin Exp Pathol; 2017; 10(7):7836-7846. PubMed ID: 31966631
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide miRNA profiling in myelodysplastic syndrome with del(5q) treated with lenalidomide.
Merkerova MD; Krejcik Z; Belickova M; Hrustincova A; Klema J; Stara E; Zemanova Z; Michalova K; Cermak J; Jonasova A
Eur J Haematol; 2015 Jul; 95(1):35-43. PubMed ID: 25287904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]